Heart disease, cancer, diabetes, obesity, arthritis—chronic conditions such as these account for 84% of health care spending. Yet many are preventable. An estimated 40% of all premature deaths can be attributed to lifestyle, such as smoking and inactivity. How can the health care system shift focus (and dollars) from acute to preventative care?
Almost every day, we see announcements about yet another “connected” product that is hailed as creating a “smarter” home environment. These types of products promise an easier, more convenient way of living, but they aren’t always connected to our lives—or all that smart.
AstraZeneca PLC on Wednesday said its MedImmune research and development arm has secured orphan drug designation for its MEDI-551 drug from the US Food & Drug Administration.
The drugmaker said MEDI-551 is used to treat patients with neuromyelitis optica, an autoimmune disease of the central nervous system by which the body’s immune system attacks healthy cells, most commonly in the optic nerves and spinal cord.
It was one major issue U.S. Commerce Secretary Penny Pritzker and National Urban League President Marc Morial discussed with entrepreneurs Monday.
AstraZeneca announced that its global biologics research and development arm, MedImmune, has received Fast Track designation from the US Food and Drug Administration (FDA) for its investigational human monoclonal antibody (mAb), MEDI8852, for the treatment of patients hospitalised with Type A strain influenza. The FDA’s Fast Track programme is designed to expedite the development and review of drugs to treat serious conditions and fill an unmet medical need.
It looks like Healthbox is raising a new fund, according to a Form D filing with the U.S. Securities and Exchange Commission. The accelerator is keeping schtum about the Healthbox Opportunity Fund I and declined a request for comment.
Still, its website shows that it is poised to bring its Healthbox Studio accelerators to Orlando, as part of a partnership with Guidewell Innovation Center, and Los Angeles later this year. Healthbox and Guidewell had previous accelerator classes in Miami, Tampa Bay and Jacksonville. Los Angeles is home to a few accelerators, including one between Techstars and Cedars-Sinai.
A University of Maryland startup is among the finalists in Under Armour CEO Kevin Plank’s Cupid’s Cup, a competition offering a $100,000 prize of the winner.
Companies founded on technology licensed from Johns Hopkins University have raised $1 billion since 2010. And 90 percent of those companies are no longer in Maryland.
Christy Wyskiel, who leads Johns Hopkins Technology Ventures, the university’s commercialization arm, hopes to reverse that trend with a new partnership with Village Capital and the Abell Foundation.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for its BD Totalys MultiProcessor and BD Totalys SlidePrep instruments.
Innovation takes time – and money, and people and resources. That’s why it’s common for a company to focus on core business activities and not build an innovation lab – a specific building or department dedicated to working on prototypes and fleshing out ideas.
